
    
      LEGDEB2 is a Global Registry aimed to prospectively collect and assess global safety and
      efficacy data on the Legflow Drug Eluting Balloon (DEB) in treatment of atherosclerotic
      disease of the superficial femoral and/or popliteal and/or below-the-knee and/or iliac
      arteries in "real world" patient population.
    
  